Background: The efficacy of Cognitive Behavior Therapy (CBT) for depression has been robustly supported, however, up to fifty percent of individuals do not respond fully. A growing body of research indicates Schema Therapy (ST) is an effective treatment for difficult and entrenched problems, and as such, may be an effective therapy for depression. Methods: In this randomized clinical trial the comparative efficacy of CBT and ST for depression was examined. 100 participants with major depression received weekly cognitive behavioral therapy or schema therapy sessions for 6 months, followed by monthly therapy sessions for 6 months. Key outcomes were comparisons over the weekly and monthly sessions of therapy along with remission and recovery rates. Additional analyses examined outcome for those with chronic depression and comorbid personality disorders. Results: ST was not significantly better (nor worse) than CBT for the treatment of depression. The therapies were of comparable efficacy on all key outcomes. There were no differential treatment effects for those with chronic depression or comorbid personality disorders. Limitations: This study needs replication. Conclusions: This preliminary research indicates that ST may provide an effective alternative therapy for depression.
Introduction
Cognitive behavior therapy (CBT) is recommended as one of the first-line treatments for individuals with major depression (Ellis et al., 2003 ; National Institute for Clinical Excellence (NICE), 2004) . Despite the proven effectiveness of CBT only 40-50% with depression will make a full recovery with their first course of treatment, and some are likely to have a poor outcome despite completing treatment. Moreover, 3-5% may develop a chronic clinical course of depression which is resistant to treatment (Fournier et al., 2009; Hollon et al., 2005; Kessler et al., 1994) . Other than chronicity, a number of other factors have been proposed to limit the effectiveness of CBT. Perhaps with the most contradictory evidence, is the treatment outcome when personality disorders are comorbid. A number of studies indicate that treatments are less effective when a comorbid personality disorder is present (e.g. Bagby et al., 2008; Gorwood et al., 2010) , with a recent meta analysis reporting the risk of poor outcome doubles (Newton-Howes et al., 2006) . Other studies and reviews report no difference in outcome between depressed individuals with and without personality disorders (Kelly et al., 2009; Kool et al., 2005; Niemeyer and Musch, 2013; van den Hout et al., 2006) .
Limitations in the effectiveness of traditional CBT for depression, and growing recognition that depression is a chronic and/or recurrent disorder for many people often associated with other comorbid axis I and II problems, has led to increased use by clinicians of Schema Therapy (ST) in the treatment of depression. Schema Therapy was initially developed by Young (1990) for the treatment of personality dysfunction. In contrast to traditional CBT, ST concentrates immediately and specifically on the schema and related developmental processes that prevent individuals having their core needs met in an adaptive manner. It has been proposed that these schema must be modified in order to bring about lasting change, particularly for individuals with more difficult or entrenched problems such as chronic or recurrent depression (Overholser, 1997; Riso et al., 2003; Safran and Segal, 1990; Young, 1990) . Further, it has been proposed that any treatment that fails to reorganize or disrupt these fundamental assumptions leaves people cognitively at risk for the reactivation of maladaptive schemas during times of personal stress (Segal et al., 1988) , and therefore at increased risk of depression reoccurring. These propositions are supported by research indicating that therapy that focuses more on interpersonal and developmental issues promotes long lasting recovery from depression and, importantly, reduces the risk of relapse (Hayes et al., 1996) . Schema change has been Schema therapy (ST) is an integrative treatment approach combining cognitive, behavioral, experiential, and psychodynamic elements and techniques (Young, Klosko, & Weishaar, 2003) . Influenced by the cognitive theory of depression, Young elaborated on the schema concept and developed ST as a novel treatment for clients with chronic psychological disorders. Empirical research on the effectiveness of ST is in its initial stage. While there is evidence for the effectiveness of ST in treating clients with borderline personality disorder (Farrell, Shaw, & Webber, 2009; Giesen-Bloo et al., 2006; Nadort et al., 2009; Nordahl, Holthe, & Haugum, 2005) and clients with Cluster-C, paranoid, histrionic, and narcissistic personality disorders (Bamelis, Evers, Spinhoven, & Arntz, 2012), there is a lack of research on ST for chronic Axis I disorders. In addition to the effects of ST on personality pathology, a recent large randomized controlled trial found that ST also has positive effects on comorbid depression in clients with primarily Cluster-C personality disorders (Bamelis et al., 2012) . Such findings raise the question whether ST is also a valuable treatment for clients with primary depressive symptoms.
Chronic depression is a relatively common (affecting 19% of depressed clients; Keller & Hanks, 1995) and difficult to treat (Kocsis, 2003; Riso & Newman, 2003) mental disorder. Four types of chronic depression are distinguished in the literature: chronic major depressive disorder, dysthymic disorder, double depression, and recurrent major depressive disorder (MDD) without full interepisode recovery (Klein, 2010) . Whereas these subtypes appear to be rather homogenous with respect to etiology and clinical features, they can be clinically distinguished from episodic forms of depression (McCullough et al., 2003) . Compared with episodic forms of depression, chronic depression has a stronger ORIGINAL ARTICLE
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Randomized Trial of Schema-Focused Therapy vs Transference-Focused Psychotherapy
Josephine Giesen-Bloo, MSc; Richard van Dyck, MD, PhD; Philip Spinhoven, PhD; Willem van Tilburg, MD, PhD; Carmen Dirksen, PhD; Thea van Asselt, MSc; Ismay Kremers, PhD; Marjon Nadort, MSc; Arnoud Arntz, PhD Context: Borderline personality disorder is a severe and chronic psychiatric condition, prevalent throughout health care settings. Only limited effects of current treatments have been documented.
Objective: To compare the effectiveness of schemafocused therapy (SFT) and psychodynamically based transference-focused psychotherapy (TFP) in patients with borderline personality disorder.
Design: A multicenter, randomized, 2-group design.
Setting: Four general community mental health centers.
Participants: Eighty-eight patients with a Borderline Personality Disorder Severity Index, fourth version, score greater than a predetermined cutoff score.
Intervention: Three years of either SFT or TFP with sessions twice a week.
Main Outcome Measures:
Borderline Personality Disorder Severity Index, fourth version, score; quality of life; general psychopathologic dysfunction; and measures of SFT/TFP personality concepts. Patient assessments were made before randomization and then every 3 months for 3 years.
Results: Data on 44 SFT patients and 42 TFP patients were available. The sociodemographic and clinical characteristics of the groups were similar at baseline. Survival analyses revealed a higher dropout risk for TFP patients than for SFT patients (P=.01). Using an intentionto-treat approach, statistically and clinically significant improvements were found for both treatments on all measures after 1-, 2-, and 3-year treatment periods. After 3 years of treatment, survival analyses demonstrated that significantly more SFT patients recovered (relative risk=2.18; P=.04) or showed reliable clinical improvement (relative risk=2.33; P=.009) on the Borderline Personality Disorder Severity Index, fourth version. Robust analysis of covariance (ANCOVA) showed that they also improved more in general psychopathologic dysfunction and measures of SFT/TFP personality concepts (PϽ.001). Finally, SFT patients showed greater increases in quality of life than TFP patients (robust ANCOVAs, P=.03 and PϽ.001).
Conclusions: Three years of SFT or TFP proved to be effective in reducing borderline personality disorderspecific and general psychopathologic dysfunction and measures of SFT/TFP concepts and in improving quality of life; SFT is more effective than TFP for all measures. Psychiatry. 2006; 63:649-658 B ORDERLINE PERSONALITY DISorder (BPD) is marked by chronicinstabilityinmultiple areas (ie, emotional dysregulation, self-harm, impulsivity, and identity disturbance). The prevalence of BPD is estimated to be 1% to 2.5% in the general population and 10% to 50% in psychiatric outpatient and inpatient settings. have demonstrated some effectiveness in randomized clinical trials of patients with BPD, as manifested by good treatment retention and reduced suicide attempts, acts of self-harm, and hospitalizations. However, no pharmacologic or psychosocial treatment has demonstrated efficacy for all aspects of BPD, such as affective, identity, and interpersonal disturbances.
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We compared the effectiveness of 2 prolonged outpatient treatments that aim at achieving full recovery from BPD: schemafocused therapy (SFT)
13-15 and transference-focused psychotherapy (TFP). 16, 17 Schema-focused therapy is an integrative cognitive therapy, and TFP is a psychodynamically based psychotherapy. Both treatments intend to bring about a struc-
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Schema therapy (ST) with the schema mode approach is currently one of the major developments in CBT for personality disorders. The schema mode model includes both a general approach to treatment as well as specific variants for each personality disorder. The first specific mode model has been defined for borderline personality disorder. Treatment based on this model has been found to be very effective in several studies. A meta-analysis of these studies is presented. Further mode models have also been defined for most personality disorders and for forensic patients. Preliminary results of studies in these patient groups are also promising. Important current and future developments include applications of ST in other treatment settings (i.e., group and inpatient treatment), and the development of approaches for chronic Axis I disorders. Important topics for future research include direct comparisons of ST to other active treatment conditions, dismantling studies, and more fundamental investigations of experiential treatment techniques. However, very few approaches have extended their application to other personality disorders. To the best of our knowledge, only the schema therapy approach has explicated models for the majority of the personality disorders. Hence this paper focuses on ST as a major current development in the field of cognitive therapies for personality disorders.
Recent developments in psychotherapy for personality disorders have focused on
A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: A randomized controlled trial 
a b s t r a c t
This study tests the effectiveness of adding an eight-month, thirtysession schema-focused therapy (SFT) group to treatment-as-usual (TAU) individual psychotherapy for borderline personality disorder (BPD). Patients (N ¼ 32) were randomly assigned to SFT-TAU and TAU alone. Dropout was 0% SFT, 25% TAU. Significant reductions in BPD symptoms and global severity of psychiatric symptoms, and improved global functioning with large treatment effect sizes were found in the SFT-TAU group. At the end of treatment, 94% of SFT-TAU compared to 16% of TAU no longer met BPD diagnosis criteria (p < .001). This study supports group SFT as an effective treatment for BPD that leads to recovery and improved overall functioning. Ó 2009 Elsevier Ltd. All rights reserved.
Introduction
Borderline personality disorder (BPD) is a disabling and prevalent psychiatric disorder, which is characterized by substantial distress and disruptions in functioning. Patients with BPD experience a chronic pervasive pattern of instability in areas of affect, behavior, interpersonal relationships, identity, and cognition. It is a disorder with high prevalence -1-2% in the general population and up to 25% or more in clinical populations, depending upon the study (Lieb, Zanarini, Schmahl, Linehan, & Bohus, 2004 ). Prevalence appears to be increasing, as recently the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions found a prevalence rate of 5.9% for BPD in the general population (Grant, Chou, Goldstein, Huang, Stinson, Saha, et al., 2008) . Although several medications Borderline personality disorder is well known as a severe psychiatric condition. The prevalence of this disorder is estimated at 1-2.5% in the worldwide population, 1 and at 10-50% among psychiatric patients. Societal costs associated with borderline personality disorder are substantial.
2 Recently, the effectiveness of two out-patient psychotherapies -schema-focused therapy (SFT) and transference-focused psychotherapy (TFP) -was compared.
3 Both treatments aim to achieve full recovery from the disorder, unlike other therapies. 4 In that comparison both forms of therapy succeeded in reducing disorder-specific and general psychopathologic dysfunction, and improving health-related quality of life, with SFT being more effective on all measures. However, the most effective treatment is not necessarily the most cost-effective treatment. In the context of healthcare budget constraints, an economic evaluation can inform decisions concerning which healthcare services to offer to patients. Therefore, a cost-effectiveness analysis was performed comparing these two forms of therapy.
Method Patients and assessments
In a multicentre trial in The Netherlands, 86 patients from four study locations were randomly allocated to either SFT (n=44) or TFP (n=42). A pre-randomisation assessment was performed; subsequently, 3-monthly assessments were made for 3 years, with a final follow-up assessment 4 years after the baseline interviews. Both interventions were individual therapies consisting of 50 min sessions twice a week for 3 years. Central to SFT is the assumption of four schema modes specific to borderline personality disorder; recovery is achieved when dysfunctional schemas no longer control or rule the patient's life. Central to TFP is a negotiated treatment contract between patient and therapist, being the treatment frame; recovery is reached when good and bad representations of self (and others) are integrated and when fixed, primitive internalised object relations are resolved. Twelve participants in the SFT group and 22 in the TFP group left the study early. A further 6 (14%) participants in the SFT group and 2 (5%) in the TFP group successfully (according to therapist and patient) terminated treatment within 3 years. For details, see Giesen-Bloo et al.
3
Resources used
At every assessment a structured cost interview was administered by an independent research assistant. Formal registries such as hospital information systems or insurer's databases are considered to be incomplete, since a considerable amount of resource use is situated outside (mental) healthcare institutions.
5 Besides, individual patient data cannot be traced from registries. Therefore, patient-reported prospective cost diaries, 6 or retrospective cost interviews, 7 are the preferred instruments covering all relevant events. We chose a 3-month recall interview, 8 since a prospective cost diary was expected to lead to more missing items, given the patient characteristics. From a societal perspective, the cost interview covered work status and absence, sources of income, domestic activities, informal care, medication use, alcohol and drugs, out-of-pocket expenses, and consumption of healthcare and societal resources (including visits to general practitioners,
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Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy Antoinette D. I. van Asselt, Carmen D. Dirksen, Arnoud Arntz, Josephine H. Giesen-Bloo, Richard van Dyck, Philip Spinhoven, Willem van Tilburg, Ismay P. Kremers, Marjon Nadort and Johan L. Severens Background Schema-focused therapy (SFT) and transference-focused psychotherapy (TFP) for borderline personality disorder were recently compared in a randomised multicentre trial.
Aims
To assess the societal cost-effectiveness of SFT v. TFP in treating borderline personality disorder.
Method
Costs were assessed by interview. Health-related quality of life was measured using EQ-5D. Outcomes were costs per recovered patient (recovery assessed with the Borderline Personality Disorder Severity Index) and costs per qualityadjusted life-year (QALY).
Results
Mean 4-year bootstrapped costs were e37 826 for SFT and e46 795 for TFP (95% uncertainty interval for difference 721 775 to 3546); QALYs were 2.15 for SFT and 2.27 for TFP (95% UI 70.51 to 0.28). The percentages of patients who recovered were 52% and 29% respectively. The SFT intervention was less costly and more effective than TFP (dominant), for recovery; it saved e90 457 for one QALY loss.
Conclusions
Despite the initial slight disadvantage in QALYs, there is a high probability that compared with TFP, SFT is a cost-effective treatment for borderline personality disorder.
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The British Journal of Psychiatry (2008 Psychiatry ( ) 192, 450-457. doi: 10.1192 Objective: The authors compared the effectiveness of 50 sessions of schema therapy with clarification-oriented psychotherapy and with treatment as usual among patients with cluster C, paranoid, histrionic, or narcissistic personality disorder.
Method: A multicenter randomized controlled trial, with a single-blind parallel design, was conducted between 2006 and 2011 in 12 Dutch mental health institutes. A total of 323 patients with personality disorders were randomly assigned (schema therapy, N=147; treatment as usual, N=135; clarification-oriented psychotherapy, N=41). There were two cohorts of schema therapy therapists, with the first trained primarily with lectures and the second primarily with exercises. The primary outcome was recovery from personality disorder 3 years after treatment started (assessed by blinded interviewers). Secondary outcomes were dropout rates and measures of personality disorder traits, depressive and anxiety disorders, general psychological complaints, general and social functioning, self-ideal discrepancy, and quality of life.
Results: A significantly greater proportion of patients recovered in schema therapy compared with treatment as usual and clarification-oriented psychotherapy. Second-cohort schema therapists had better results than first-cohort therapists. Clarification-oriented psychotherapy and treatment as usual did not differ. Findings did not vary with specific personality disorder diagnosis. Dropout was lower in the schema therapy and clarification-oriented psychotherapy conditions. All treatments showed improvements on secondary outcomes. Schema therapy patients had less depressive disorder and higher general and social functioning at follow-up. While interview-based measures demonstrated significant differences between treatments, differences were not found with self-report measures.
Conclusions: Schema therapy was superior to treatment as usual on recovery, other interview-based outcomes, and dropout. Exercise-based schema therapy training was superior to lecturebased training. Per sonality disorders are complex mental health problems associated with chronic dysfunction in several life domains (social, work, self-care) (1, 2), reduced quality of life (3), high societal costs (4), and a high prevalence rate (3%-15% in the general population) (5). Although psychological treatment is considered to be the treatment of choice for personality disorders (6, 7), research into its effectiveness is still in its infancy, troubled with methodological issues and strongly focused on borderline personality disorder. Studying the effectiveness of treatment for understudied personality disorders is a highly prioritized recommendation in several reviews (8-10).
Schema therapy is a form of psychotherapy that has proven to be efficacious for borderline personality disorder. A randomized controlled trial comparing schema therapy with transference-focused psychotherapy found dominance of schema therapy over transference-focused psychotherapy on all outcome measures and a significantly lower dropout rate in schema therapy (11). Schema therapy also proved to be a more cost-effective treatment (12). A subsequent study found that schema therapy can be successfully implemented in regular mental health care (13). Another study reported superiority of schema therapy over treatment as usual for borderline personality disorder (14). However, the effectiveness of schema therapy for personality disorders other than borderline personality disorder remains to be evaluated.
The main objective of the present randomized controlled trial was to examine the clinical effectiveness of schema therapy for a group of six personality disorders: cluster C (avoidant, dependent, and obsessive-compulsive), histrionic, narcissistic, and paranoid personality disorders. Other personality disorders were excluded because they were deemed to require highly specialized and lengthier treatment protocols. A treatment protocol of 50 schema therapy sessions was compared with treatment as usual, 
Abstract
According to Dutch Law, patients committing severe crimes justifying imprisonment of four years or more who cannot be held (fully) accountable for these acts can be sentenced to compulsory hospitalization in a specialized TBS hospital in the Netherlands. In the current paper, the effects of TBS treatment will be addressed in terms of recidivism numbers after termination of TBS treatment, as well as in behavioral changes that are observed during admission to TBS hospitals. Although these results offer some indirect support suggesting that TBS is effective, no randomized controlled trials had been conducted up until now that could confirm this. In the current study, preliminary results are reported from a multicenter randomized clinical trial on the effectiveness of Schema Therapy (ST) for hospitalized TBS patients with Antisocial, Borderline, Narcissistic, or Paranoid Personality Disorders, including those with high levels of psychopathy. Patients at seven TBS clinics were randomly assigned to receive three years of either ST or Treatment As Usual (TAU), and are being assessed on several outcome variables, such as recidivism risk (HCR-20, START), personality disorder symptoms (SIDP-IV, SNAP), and successful re-integration into the community. A threeyear follow-up study will examine actual recidivism. One hundred and two patients are participating in the study. The preliminary findings from the first 30 patients to complete the three-year study suggest that ST is yielding better outcomes than TAU with regard to reducing recidivism risk and promoting re-entry into the community. These findings are not yet statistically significant, and thus need to be interpreted with caution until confirmed in our complete sample and follow up. However, they suggest that ST may be a promising treatment for offenders with personality disorders, including some psychopathic ones.
